NCT05142358View on ClinicalTrials.gov

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

NAActive, not recruitingINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 19, 2022

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Lung CancerLeft Sided Breast Cancer
Interventions
DEVICE

Continuous Positive Airway Pressure

Use of CPAP device at the start of treatment planning.

OTHER

Deep inspiratory breath hold

Treatment during breath holds leads to longer treatment times for patients and radiation oncology departments

OTHER

Free Breath

Regular breathing

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

Sponsors

Collaborators (1)

Varian Medical Systems
All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

Case Comprehensive Cancer Center

OTHER

NCT05142358 - A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose | Biotech Hunter | Biotech Hunter